With 34% ownership, Design Therapeutics, Inc. (NASDAQ:DSGN) has piqued the interest of institutional investors

By Yahoo! Finance | Aug 16, 2024 at 06:25 AM EST

Institutions' significant holdings in Design Therapeutics (NASDAQ:DSGN) indicate control over its share price. Institutional investors, hedge funds, insiders, and private equity firms all play a role in influencing the company's performance and future prospects.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.